SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-047490
Filing Date
2023-06-08
Accepted
2023-06-08 16:30:09
Documents
13
Period of Report
2023-06-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea180001-8k_biomxinc.htm   iXBRL 8-K 32199
  Complete submission text file 0001213900-23-047490.txt   261333

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phgeu-20230602.xsd EX-101.SCH 4220
3 XBRL DEFINITION FILE phgeu-20230602_def.xml EX-101.DEF 27468
4 XBRL LABEL FILE phgeu-20230602_lab.xml EX-101.LAB 38237
5 XBRL PRESENTATION FILE phgeu-20230602_pre.xml EX-101.PRE 26088
7 EXTRACTED XBRL INSTANCE DOCUMENT ea180001-8k_biomxinc_htm.xml XML 7476
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 231002307
SIC: 2836 Biological Products, (No Diagnostic Substances)